Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Moxifloxacin Hydrochloride Injection

Approval Number

国药准字H20193203

Company江苏海岸药业有限公司

Registration Date

July 4, 2019

Drug Information

Generic Name

盐酸莫西沙星注射液

Dosage Form

注射剂

Strength

20ml:0.4g(按C21H24FN3O4计)

Drug Type

化学药品

Registration Date

July 4, 2019

Company Information

Applicant Company

Company Name江苏海岸药业有限公司

Company Address

江苏省苏州市吴江区黎里镇芦墟国道路2688号

Manufacturing Company

Company Name扬子江药业集团有限公司

Company Address

江苏省泰州市扬子江南路1号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy